US Patent 7893096 Use of small molecule compounds for immunopotentiation
Patent 7893096 was granted and assigned to Novartis on February, 2011 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 29, 2004
Date of Patent
February 22, 2011
Patent Application Number
10814480
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7893096 Use of small molecule compounds for immunopotentiation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
